Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management of translocation carcinomas of the kidney

12 Aug 2024

Abstract excerpt

Microphthalmia-associated transcription factor family translocation renal cell carcinoma (MiT-tRCC) stands out as a rare subtype of kidney cancer with distinct biological features compared to other kidney cancer subtypes. It encompasses TFE3-rearranged RCC (also known as Xp11 translocation RCC) and TFE-rearranged translocations RCC, although multiple new fusion partners were identified. Traditionally thought to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple and Secondary Primary Cancers
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39697715
DOI: 10.21037/tcr-24-60

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management of translocation carcinomas of the kidneyPMID 39697715Read ↗

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular InsightsSemantic proximity Read ↗

Translocation carcinomas of the kidneySemantic proximity Read ↗

Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell CarcinomasSemantic proximity Read ↗

MiT family translocation renal cell carcinomas: A 15th anniversary update.Semantic proximity Read ↗

Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular FeaturesSemantic proximity Read ↗

Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomasSemantic proximity Read ↗

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinomaSemantic proximity Read ↗

Microphthalmia family of transcription factors associated renal cell carcinomaSemantic proximity Read ↗

MiT family translocation renal cell carcinoma in an elderly maleSemantic proximity Read ↗

An engineered tumor organoid model reveals cellular identity and signaling trajectories underlying translocation RCCSemantic proximity Read ↗

MiT Family Translocation-Associated Renal Cell Carcinoma: A Contemporary Update With Emphasis on Morphologic, Immunophenotypic, and Molecular MimicsSemantic proximity Read ↗

Pembrolizumab combined with Axitinib in ASPSCR1-TFE3 gene fusion translocation renal cell carcinoma: a case report and literature reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.